Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy
Ontology highlight
ABSTRACT: Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy
PROVIDER: PRJNA1179864 | ENA |
REPOSITORIES: ENA
ACCESS DATA